OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 2, 2013, Pages

  Ilves, T ^a   Harvima, I T ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; MONOCLONAL ANTIBODY; OX40 LIGAND; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CELL MEMBRANE; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE RELEASE; DERMIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KERATINOCYTE; MALE; MAST CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; SKIN BIOPSY;

ADULT; AGED; CELL PROLIFERATION; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOCYTES; OX40 LIGAND; RECEPTORS, OX40; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84872674689     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04587.x     Document Type: Article

References (39)

1. Higashi N, Bang K, Gesser B, et al., Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol 2001; 81: 3-7.
2. Wang YH, Liu YJ,. OX40-OX40L interactions: a promising therapeutic target for allergic diseases? J Clin Invest 2007; 117: 3655-3657.
3. Godfrey WR, Fagnoni FF, Harara MA, et al., Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J Exp Med 1994; 180: 757-762.
4. Ohshima Y, Tanaka Y, Tozawa H, et al., Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997; 159: 3838-3848.
5. Miura S, Ohtani K, Numata N, et al., Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol 1991; 11: 1313-1325.
6. Imura A, Hori T, Imada K, et al., The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 1996; 183: 2185-2195.
7. Paterson DJ, Jefferies WA, Green JR, et al., Antigens of activated rat T lymphocytes including a molecule of 50,000 mr detected only on CD4 positive T blasts. Mol Immunol 1987; 24: 1281-1290.
8. Croft M,. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 2010; 28: 57-78.
9. Edwards MJ,. Therapy directed against thymic stromal lymphopoietin. Drug News Perspect 2008; 21: 312-316.
10. Ito T, Wang YH, Duramad O, et al., TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202: 1213-1223.
11. Allakhverdi Z, Comeau MR, Jessup HK, et al., Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204: 253-258.
12. Soumelis V, Reche PA, Kanzler H, et al., Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3: 673-680.
13. Liu YJ,. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 2007; 120: 238-244; quiz 245-246.
14. Kashiwakura J, Yokoi H, Saito H, Okayama Y,. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 2004; 173: 5247-5257.
15. Rajka G, Langeland T,. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989; 144: 13-14.
16. Hongbo Y, Thomas CL, Harrison MA, et al., Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
17. Ackermann L, Harvima IT,. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 1998; 290: 353-359.
18. Ackermann L, Harvima IT, Pelkonen J, et al., Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 1999; 140: 624-633.
19. Horsmanheimo L, Harvima IT, Jarvikallio A, et al., Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994; 131: 348-353.
20. Kirshenbaum AS, Akin C, Wu Y, et al., Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 2003; 27: 677-682.
21. Maeda T, Balakrishnan K, Mehdi SQ,. A simple and rapid method for the preparation of plasma membranes. Biochim Biophys Acta 1983; 731: 115-120.
22. Rasanen L, Tuomi ML,. Diagnostic value of the lymphocyte proliferation test in nickel contact allergy and provocation in occupational coin dermatitis. Contact Dermatitis 1992; 27: 250-254.
23. Matsumura Y, Imura A, Hori T, et al., Localization of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T cells and endothelial cells in infiltration. Arch Dermatol Res 1997; 289: 653-656.
24. Matsumura Y, Hori T, Nishigori C, et al., Expression of CD134 and CD134 ligand in lesional and nonlesional psoriatic skin. Arch Dermatol Res 2003; 294: 563-566.
25. Nakae S, Suto H, Iikura M, et al., Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176: 2238-2248.
26. Seshasayee D, Lee WP, Zhou M, et al., In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest 2007; 117: 3868-3878.
27. Kunitomi A, Hori T, Imura A, Uchiyama T,. Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system. J Leukoc Biol 2000; 68: 111-118.
28. Wang YH, Ito T, Wang YH, et al., Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 2006; 24: 827-838.
29. Bengtsson A,. The role of CD30 in atopic disease. Allergy 2001; 56: 593-603.
30. Jung K, Linse F, Heller R, et al., Adhesion molecules in atopic dermatitis: VCAM-1 and ICAM-1 expression is increased in healthy-appearing skin. Allergy 1996; 51: 452-460.
31. Fischer M, Harvima IT, Carvalho RF, et al., Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 2006; 116: 2748-2756.
32. Yamamoto J, Adachi Y, Onoue Y, et al., CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 2000; 55: 1011-1018.
33. Bengtsson A, Scheynius A, Avila-Carino J,. Crosslinking of CD30 on activated human th clones enhances their cytokine production and downregulates the CD30 expression. Scand J Immunol 2000; 52: 595-601.
34. Fox CC, Jewell SD, Whitacre CC,. Rat peritoneal mast cells present antigen to a PPD-specific T cell line. Cell Immunol 1994; 158: 253-264.
35. Takiguchi R, Tofte S, Simpson B, et al., Efalizumab for severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol 2007; 56: 222-227.
36. Simon JC, Cruz PD Jr, Bergstresser PR, et al., Phorbol myristate acetate-activated keratinocytes stimulate proliferation of resting peripheral blood mononuclear lymphocytes via a MHC-independent, but protein kinase C- and intercellular adhesion molecule-1-dependent, mechanism. J Immunol 1991; 146: 476-484.
37. Kuschei WM, Leitner J, Majdic O, et al., Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody efalizumab. Clin Immunol 2011; 139: 199-207.
38. Piconese S, Gri G, Tripodo C, et al., Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. Blood 2009; 114: 2639-2648.
39. Ukyo N, Hori T, Yanagita S, et al., Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response. Immunology 2003; 109: 226-231.